These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8540349)

  • 1. Identification of amino acid residues of the retroviral aspartic proteinases important for substrate specificity and catalytic efficiency.
    Cameron CE; Burstein H; Bizub-Bender D; Ridky T; Weber IT; Wlodawer A; Skalka AM; Leis J
    Adv Exp Med Biol; 1995; 362():399-406. PubMed ID: 8540349
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular modeling of the structure of FIV protease.
    Gustchina A
    Adv Exp Med Biol; 1995; 362():479-84. PubMed ID: 8540361
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.
    Tözsér J; Zahuczky G; Bagossi P; Louis JM; Copeland TD; Oroszlan S; Harrison RW; Weber IT
    Eur J Biochem; 2000 Oct; 267(20):6287-95. PubMed ID: 11012683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed mutagenesis of HIV-1 protease: generation of mutant proteases with increased stability to autodigestion.
    Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson R
    Adv Exp Med Biol; 1995; 362():473-7. PubMed ID: 8540360
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.
    Cameron CE; Ridky TW; Shulenin S; Leis J; Weber IT; Copeland T; Wlodawer A; Burstein H; Bizub-Bender D; Skalka AM
    J Biol Chem; 1994 Apr; 269(15):11170-7. PubMed ID: 8157644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of precursor and tethered dimer forms of HIV proteinase.
    Phylip LH; Griffiths JT; Mills JS; Graves MC; Dunn BM; Kay J
    Adv Exp Med Biol; 1995; 362():467-72. PubMed ID: 8540359
    [No Abstract]   [Full Text] [Related]  

  • 7. A quantum mechanical model of the hydration and acidity of the active site in aspartic proteases.
    Topol IA; Cachau RE; Burt SK; Erickson JW
    Adv Exp Med Biol; 1995; 362():549-54. PubMed ID: 8540370
    [No Abstract]   [Full Text] [Related]  

  • 8. X-ray structures of retroviral proteases and their inhibitor-bound complexes.
    Ringe D
    Methods Enzymol; 1994; 241():157-77. PubMed ID: 7854176
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV protease: a novel chemotherapeutic target for AIDS.
    Huff JR
    J Med Chem; 1991 Aug; 34(8):2305-14. PubMed ID: 1875332
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.
    Powell DJ; Bur D; Wlodawer A; Gustchina A; Payne SL; Dunn BM; Kay J
    Eur J Biochem; 1996 Oct; 241(2):664-74. PubMed ID: 8917470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsite preferences of retroviral proteinases.
    Dunn BM; Gustchina A; Wlodawer A; Kay J
    Methods Enzymol; 1994; 241():254-78. PubMed ID: 7854181
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate.
    Ridky TW; Kikonyogo A; Leis J; Gulnik S; Copeland T; Erickson J; Wlodawer A; Kurinov I; Harrison RW; Weber IT
    Biochemistry; 1998 Sep; 37(39):13835-45. PubMed ID: 9753473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases.
    Cameron CE; Grinde B; Jacques P; Jentoft J; Leis J; Wlodawer A; Weber IT
    J Biol Chem; 1993 Jun; 268(16):11711-20. PubMed ID: 8389361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis.
    Culberson JC; Bush BL; Sardana VV
    Methods Enzymol; 1994; 241():385-94. PubMed ID: 7854190
    [No Abstract]   [Full Text] [Related]  

  • 15. Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor.
    Bhat TN; Baldwin ET; Liu B; Cheng YS; Erickson JW
    Nat Struct Biol; 1994 Aug; 1(8):552-6. PubMed ID: 7664084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new way of looking at aspartic proteinase structures: a comparison of pepsin structure to other aspartic proteinases in the near active site region.
    Andreeva NS; Bochkarev A; Pechik I
    Adv Exp Med Biol; 1995; 362():19-32. PubMed ID: 8540318
    [No Abstract]   [Full Text] [Related]  

  • 17. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.
    Ridky TW; Cameron CE; Cameron J; Leis J; Copeland T; Wlodawer A; Weber IT; Harrison RW
    J Biol Chem; 1996 Mar; 271(9):4709-17. PubMed ID: 8617736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking the shackles of the genetic code: engineering retroviral proteases through total chemical synthesis.
    Kent SB; Baca M; Elder J; Miller M; Milton R; Milton S; Rao JK; Schnölzer M
    Adv Exp Med Biol; 1995; 362():425-38. PubMed ID: 8540353
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization.
    Ingr M; Uhlíková T; Strísovský K; Majerová E; Konvalinka J
    Protein Sci; 2003 Oct; 12(10):2173-82. PubMed ID: 14500875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
    Tomasselli AG; Heinrikson RL
    Methods Enzymol; 1994; 241():279-301. PubMed ID: 7854182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.